Related Experiment Video
Updated: Aug 11, 2026

03:22
Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases
Published on: March 1, 2024
Drug eruptions at five institutes in Bangkok
Siripen Puavilai1, Nopadon Noppakun, Chasuree Sitakalin
1Division of Dermatology, Department of Medicine, Ramathibodi Hospital Medical School, Mahidol University, Bangkok 10400, Thailand.
Journal of the Medical Association of Thailand = Chotmaihet Thangphaet
|February 14, 2006
Summary
Antimicrobial agents, particularly cephalosporins, were the leading cause of drug eruptions in Bangkok. Maculopapular rash was the most frequent clinical manifestation observed in patients.
Area of Science:
- Dermatology
- Pharmacology
- Clinical Medicine
Background:
- Drug eruptions are a common adverse drug reaction.
- Identifying causative agents and clinical patterns is crucial for patient management.
Purpose of the Study:
- To investigate the epidemiological characteristics of drug eruptions.
- To identify the most common causative drugs and clinical presentations in a Thai population.
Main Methods:
- Prospective study conducted in five Bangkok hospitals over one year (2001).
- Inclusion of 212 in- and outpatients with drug eruptions.
- Diagnosis confirmed via physical examination, history, skin biopsy, and oral challenge tests in select cases.
Main Results:
- Antimicrobial agents were the most frequent cause, with cephalosporins being the highest-ranking subgroup.
- Maculopapular rash was the predominant clinical manifestation, followed by urticaria and photosensitivity.
- Newer antimicrobial, anti-inflammatory, and lipid-lowering agents were also identified as potential causes.
Conclusions:
- Antimicrobial agents are the primary culprits in drug eruptions.
- Maculopapular eruption is the most common clinical presentation.
- A diverse range of medications can trigger various drug eruption patterns.
Related Concept Videos
Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
Inhalation Anthrax
Anthrax is a zoonotic disease caused by Bacillus anthracis, a Gram-positive, spore-forming bacterium. It primarily affects herbivorous animals but can be transmitted to humans through skin contact, ingestion, or inhalation of spores.Cutaneous anthrax, the most common form, typically results from direct contact with bacterial spores through skin abrasions and is generally less severe. Gastrointestinal anthrax results from eating undercooked or contaminated meat. It affects the mouth, throat, or...
Steps in Outbreak Investigation
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
Spasmolytic Agents: Chemical Classification
Spasmolytic agents are drugs used to alleviate muscle spasms and spasticity. They can be categorized into different chemical groups based on their mechanisms of action. Centrally acting spasmolytics primarily affect the spinal cord, while others directly target skeletal muscle cells.
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also promote...
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also promote...
